Lubelski Jacek, Konings Wil N, Driessen Arnold J M
Department of Molecular Microbiology, University of Groningen, Kerklaan 30, NL-9751 NN Haren, The Netherlands.
Microbiol Mol Biol Rev. 2007 Sep;71(3):463-76. doi: 10.1128/MMBR.00001-07.
Membrane proteins responsible for the active efflux of structurally and functionally unrelated drugs were first characterized in higher eukaryotes. To date, a vast number of transporters contributing to multidrug resistance (MDR transporters) have been reported for a large variety of organisms. Predictions about the functions of genes in the growing number of sequenced genomes indicate that MDR transporters are ubiquitous in nature. The majority of described MDR transporters in bacteria use ion motive force, while only a few systems have been shown to rely on ATP hydrolysis. However, recent reports on MDR proteins from gram-positive organisms, as well as genome analysis, indicate that the role of ABC-type MDR transporters in bacterial drug resistance might be underestimated. Detailed structural and mechanistic analyses of these proteins can help to understand their molecular mode of action and may eventually lead to the development of new strategies to counteract their actions, thereby increasing the effectiveness of drug-based therapies. This review focuses on recent advances in the analysis of ABC-type MDR transporters in bacteria.
负责结构和功能不相关药物主动外排的膜蛋白最初是在高等真核生物中得到表征的。迄今为止,已报道了大量导致多药耐药性的转运蛋白(多药耐药转运蛋白)存在于多种生物体中。对越来越多已测序基因组中基因功能的预测表明,多药耐药转运蛋白在自然界中普遍存在。细菌中大多数已描述的多药耐药转运蛋白利用离子驱动力,而只有少数系统已被证明依赖于ATP水解。然而,最近关于革兰氏阳性菌多药耐药蛋白的报道以及基因组分析表明,ABC型多药耐药转运蛋白在细菌耐药性中的作用可能被低估了。对这些蛋白进行详细的结构和机制分析有助于理解它们的分子作用模式,并最终可能导致开发新的策略来对抗它们的作用,从而提高基于药物的治疗效果。本综述重点关注细菌中ABC型多药耐药转运蛋白分析的最新进展。